Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
107.8 GBX | -2.00% | -2.36% | -29.63% |
Apr. 30 | Deutsche Bank Starts PZ Cussons Coverage at Buy | MT |
Apr. 30 | Deutsche says buy Barr, Britvic and Fevertree | AN |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-29.63% | 574M | B- | ||
+14.00% | 394B | C- | ||
+15.68% | 140B | B- | ||
+17.79% | 77.03B | A+ | ||
-17.63% | 43.2B | B+ | ||
-14.58% | 35.21B | - | ||
+6.89% | 35.09B | B- | ||
+13.44% | 18.89B | A- | ||
+26.23% | 17.49B | B | ||
+10.03% | 13.01B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PZC Stock
- Ratings PZ Cussons plc